CVE-2021-1130 vulnerability in Cisco Products
Published on January 13, 2021
Cisco DNA Center Cross-Site Scripting Vulnerability
A vulnerability in the web-based management interface of Cisco DNA Center software could allow an authenticated, remote attacker to conduct a cross-site scripting (XSS) attack against a user of the interface of an affected device. The vulnerability exists because the web-based management interface does not properly validate user-supplied input. An attacker could exploit this vulnerability by persuading a user to click a crafted link. A successful exploit could allow the attacker to execute arbitrary script code in the context of the interface or access sensitive, browser-based information. To exploit this vulnerability, an attacker would need to have administrative credentials on the affected device.
Vulnerability Analysis
CVE-2021-1130 is exploitable with network access, requires user interaction and user privileges. This vulnerability is considered to have a low attack complexity. The potential impact of an exploit of this vulnerability is considered to have a small impact on confidentiality and integrity, and no impact on availability.
Weakness Type
What is a XSS Vulnerability?
The software does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.
CVE-2021-1130 has been classified to as a XSS vulnerability or weakness.
Products Associated with CVE-2021-1130
stack.watch emails you whenever new vulnerabilities are published in Cisco Dna Center or Cisco Catalyst Center. Just hit a watch button to start following.
Affected Versions
Cisco Digital Network Architecture Center (DNA Center) Version n/a is affected by CVE-2021-1130Exploit Probability
EPSS (Exploit Prediction Scoring System) scores estimate the probability that a vulnerability will be exploited in the wild within the next 30 days. The percentile shows you how this score compares to all other vulnerabilities.